Managing dyslipidemia in solid organ transplant patients
Solid organ transplant recipients face an increased risk of dyslipidemia, which contributes to cardiovascular complications.Commonly used drugs such as ciclosporin and tacrolimus can aggravate and cause dyslipidemia.Immunosuppressive drugs particularly ciclosporin and tacrolimus are also known to worsen dyslipidemia in transplant recipients.Mammali